Specialists in integrated non-invasive brain stimulation and brain imaging technology, Brainbox brings together decades of technical and academic expertise to provide a wide range of technological solutions, supplementary systems, accessories, data acquisition and analysis software, and hands-on training initiatives to satisfy even the most demanding of neuroscience research studies.

Our portfolio is filled with the most exciting, innovative, and dependable neurotechnologies so that you can be confident that your data collection is the very best that it can be. With regular additions of new and emergent technologies, Brainbox is the most dynamic provider of non-invasive brain stimulation and imaging equipment on the market.

Our team of brain stimulation experts will work closely with you to design and construct bespoke, multimodal systems for your non-invasive brain stimulation studies, and with our ongoing commitment to support, guidance, and training, we’re always on hand to help when you need us.

—

In 2016, Brainbox proudly unveiled the Brainbox Initiative: a not-for-profit initiative that was designed specifically to help support, develop, and promote the cutting-edge research being carried out by early-career neuroscientists around the world.

The Brainbox Initiative works in close, ongoing collaboration with our Scientific Committee—a small group of some of the world’s foremost experts in non-invasive brain stimulation from leading universities, including Oxford University, UCL, the Donders Institute and more.

Together with our Scientific Committee, we are extremely proud to host a range of hands-on workshops; annual conference; symposia demonstrations; and prizes and awards that have reached thousands of early-career researchers from more than 200 universities and colleges worldwide and have already helped to inspire some truly groundbreaking neuroscience research studies.

—

Brainbox also works in close partnership with clinical trial contract research services provider The Science Behind.

The complexity of the brain makes drug discovery and development for diseases of the central nervous system (CNS) a huge challenge. As a result, many drugs never make it to market because they demonstrate an unexpected lack of efficacy or unexpected off-target effects. This comes at considerable cost to the pharmaceutical industry and has contributed to a decline in CNS drug development in recent years.

The Science Behind CRS can help Sponsors and CROs with some of these challenges in Phase 1 trials by working with Brainbox to provide the tools and specialist expertise to answer key questions in relation to safety and efficacy when bringing novel drug candidates to human clinical trials.